Home > PE Ratio > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
PE (Price/Earnings) Ratio

The Current P/E Ratio of STRIDES PHARMA SCIENCE is 43.07.

Share Price ₹1,392.5Nov 19,2024
Market Cap ₹12,811.0 Cr
Earnings-TTM₹297.4 CrTTM-Consolidated Results
Price/Earnings43.07xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of STRIDES PHARMA SCIENCE

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of STRIDES PHARMA SCIENCE is calculated as :

Current Market Cap [ ₹12,811.0 Cr] as on Nov 19,2024

(/) Earnings [ ₹297.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 43.07x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for STRIDES PHARMA SCIENCE , the investors are currently willing to pay 43.07 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of STRIDES PHARMA SCIENCE !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of STRIDES PHARMA SCIENCE over the last five years.

Historical PE (Price/Earnings) ratio chart of STRIDES PHARMA SCIENCE


PE Ratio Performance Analysis for STRIDES PHARMA SCIENCE

- STRIDES PHARMA SCIENCE 's latest p/e ratio is 43.07x.

- STRIDES PHARMA SCIENCE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 21.52x.

- STRIDES PHARMA SCIENCE 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, STRIDES PHARMA SCIENCE 's p/e ratio peaked in Mar2020 at 79.39x.

- STRIDES PHARMA SCIENCE 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does STRIDES PHARMA SCIENCE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
STRIDES PHARMA SCIENCE 297.4243.0712,811.0
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.25425,930.0
CIPLA LTD4,485.2226.39118,368.0
DR REDDYS LABORATORIES LTD5,406.8018.4399,671.4
ZYDUS LIFESCIENCES LTD4,298.9022.1695,280.3
DIVIS LABORATORIES LTD1,836.0086.40158,636.0
MANKIND PHARMA LTD2,124.8648.13102,273.0
TORRENT PHARMACEUTICALS LTD1,802.0058.13104,742.0
LUPIN LTD2,651.9435.1593,214.9
AUROBINDO PHARMA LTD3,598.8319.6970,869.4
ABBOTT INDIA LTD1,284.6644.9057,681.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs STRIDES PHARMA SCIENCE 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.43x
Max industry PE 86.40x
Median industry PE 38.25x
Average industry PE 40.06x



You may also like the below Video Courses